title: Mepolizumab in refractory eosinophilic asthma.
authors.forename: I D
authors.initials: ID
authors.lastname: Pavord
authors.forename: P
authors.initials: P
authors.lastname: Haldar
authors.forename: P
authors.initials: P
authors.lastname: Bradding
authors.forename: A J
authors.initials: AJ
authors.lastname: Wardlaw
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D004351:Drug Resistance; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011657:Pulmonary Eosinophilia / Q000188:drug therapy*
chemical_list: D018927:Anti-Asthmatic Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; C434107:mepolizumab